Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Tag
  • C-His
    (1)
TargetMol | Tags By Expression System
  • HEK293 Cells
    (1)
TargetMol | Tags By Species
  • Mouse
    (1)
TargetMol | Tags By SPR-compatible Buffer
  • Ready-to-use
    (1)
Filter
Search Result
Results for "

wisp 1

" in TargetMol Product Catalog
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
TargetMolTargetMolCompare
WISP1/CCN4 Protein, Mouse, Recombinant (His)
WISP1tc, WISP1i, WISP1c, WISP-1, ELM-1, CCN4
TMPK-00732
The interplay between glioma stem cells (GSCs) and the tumor microenvironment plays crucial roles in promoting malignant growth of glioblastoma (GBM), the most lethal brain tumor. WISP1 is preferentially expressed and secreted by GSCs. Silencing WISP1 markedly disrupts GSC maintenance, reduces tumor-supportive TAMs (M2), and potently inhibits GBM growth. WISP1 signals through Integrin α6β1-Akt to maintain GSCs by an autocrine mechanism and M2 TAMs through a paracrine manner.
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMol
TargetMolTargetMolCompare
WISP1/CCN4 Protein, Human, Recombinant (His)
WNT1 inducible signaling pathway protein 1, WISP1tc, WISP1i, WISP1c, CCN4
TMPY-00950
CCN4/Wnt-induced secreted protein 1 (WISP1) is a secreted, cysteine-rich, heparin-binding glycoprotein, belonging to the CCN (CTGF/CYR61/NOV) family of growth factors, and is involved in diverse biological functions such as cell growth, adhesion, migration, angiogenesis, tissue repair, and regulation of extracellular matrix. Members of the CCN family demonstrate high structural homology sharing four conserved cysteine-rich modular domains: an IGFBP (insulin-like growth factor-binding) domain, a von Willebrand type C domain, a thrombospondin domain and a C-terminal cysteine -knot domain. WISP1 is a putative downstream effector of the Wnt/Frizzled pathway that mediates diverse developmental processes, was identified as an oncogene regulated by the Wnt-1-beta-catenin pathway. Thus WISP1 may contribute to Wnt-1-mediated tumorigenesis and malignance. Expression of WISP1 in some cells results in transformation and tumorigenesis. WISP1 acts to block cell death at a late stage in the p53-mediated apoptosis pathway. It was reported that WISP1 interacts with sulfated glycoconjugates, decorin and biglycan in the ECM of connective tissue, and possibly prevents their inhibitory activity in tumor cell proliferation.
  • Inquiry Price
7-10 days
Size
QTY